Sodium Hydroxide → Bupivacaine (USAN:INN:BAN)

HRID 2220784

反応式

HRID 2220784 の反応式
[CH3:1][CH2:2][CH2:3][CH2:4][N:5]1[CH:10]([C:11]([NH:13][C:14]2[C:15]([CH3:21])=[CH:16][CH:17]=[CH:18][C:19]=2[CH3:20])=[O:12])[CH2:9][CH2:8][CH2:7][CH2:6]1.Cl.[OH-].[Na+]>O>[CH3:1][CH2:2][CH2:3][CH2:4][N:5]1[CH:10]([C:11]([NH:13][C:14]2[C:15]([CH3:21])=[CH:16][CH:17]=[CH:18][C:19]=2[CH3:20])=[O:12])[CH2:9][CH2:8][CH2:7][CH2:6]1

参加物

4

反応物 2

HCID 14798Sodium HydroxideHCID 64737Bupivacaine Hydrochloride

生成物 1

HCID 2474Bupivacaine (USAN:INN:BAN)

試薬・触媒・溶媒 1

HCID 962Water溶媒

実験手順

Bupivacaine hydrochloride (Sigma-Aldrich Corporation, St. Louis, Mo.) was dissolved in deionized (DI) water at a concentration of 40 mg/ml (saturation). A calculated amount of sodium hydroxide (in the form of 1 N solution) was added to the solution and the pH of the final mixture was adjusted to 10 to precipitate the Bupivacaine base. The precipitated product was filtered, and further washed with DI water at least three times. The precipitated product was dried at ca. 40° C. in vacuum for 24 hours.

後処理

  1. customto precipitate the Bupivacaine base
  2. filtrationThe precipitated product was filtered
  3. washfurther washed with DI water at least three times
  4. customThe precipitated product was dried at ca. 40° C. in vacuum for 24 hours

出典と根拠

ORDレコード
ord-8f98ef1c64c147ff95d61b55905fc186
出典データセット
uspto-grants-2008_05
特許番号
US07368126B2

関連ノート

読み込み中…